Priority Date: 27.10.08 (WO 2008NL50673)

Methods and means for efficient skipping of exon 45 in Duchenne Muscular Dystrophy pre-mRNA

  • Application ID: EP13160338
  • Status: PATENT GRANTED

Attorney

Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 27.10.2008 - Priority Date (WO 2008NL50673)
  • 26.06.2013 - Publication A1 (EP2607484)
  • 06.01.2016 - Publication B1 (EP2607484)

IPC Classification